Prevention of breast cancer using rexinoids: results of a phase II biomarker modulation trial using bexarotene in women at high risk of breast cancer.

被引：0
|
作者：
Brown, P. [1 ,2 ,3 ,4 ,5 ,6 ]
Arun, B. [1 ,2 ,3 ,4 ,5 ,6 ]
Miller, A. [1 ,2 ,3 ,4 ,5 ,6 ]
Isaacs, C. [1 ,2 ,3 ,4 ,5 ,6 ]
Gutierrez, C. [1 ,2 ,3 ,4 ,5 ,6 ]
Huang, J. [1 ,2 ,3 ,4 ,5 ,6 ]
Mohsin, S. [1 ,2 ,3 ,4 ,5 ,6 ]
Sneige, N. [1 ,2 ,3 ,4 ,5 ,6 ]
Kim, H. [1 ,2 ,3 ,4 ,5 ,6 ]
Sexton, K. [1 ,2 ,3 ,4 ,5 ,6 ]
Weiss, H. [1 ,2 ,3 ,4 ,5 ,6 ]
Hilsenbeck, S. [1 ,2 ,3 ,4 ,5 ,6 ]
Lamph, W. [1 ,2 ,3 ,4 ,5 ,6 ]
Negro-Vilar, A. [1 ,2 ,3 ,4 ,5 ,6 ]
Johnson, K. [1 ,2 ,3 ,4 ,5 ,6 ]
Elledge, R. [1 ,2 ,3 ,4 ,5 ,6 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] MD Anderson Canc Ctr, Houston, TX USA
[3] Canc Therapy & Res Ctr S Texas, San Antonio, TX 78229 USA
[4] Georgetown Univ, Washington, DC USA
[5] Ligand Pharmaceut, San Diego, CA USA
[6] Natl Canc Inst, Bethesda, MD USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2007年 / 106卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S181 / S182
页数：2
相关论文
共 50 条
  • [41] The RAZOR trial: a phase II prevention trial of screening plus goserilin and raloxifene versus screening alone in pre-menopausal women at increased risk of breast cancer.
    Motion, J.
    Ashcroft, L.
    Dowsett, M.
    Cuzick, J.
    Hickman, J.
    Evans, G.
    Eccles, D.
    Eeles, R.
    Greenhalgh, R.
    Affen, J.
    Bundred, S.
    Boggis, C.
    Sergeant, J.
    Fallowfield, L.
    Adams, J.
    Howell, A.
    CANCER RESEARCH, 2012, 72
  • [42] Accurate Identification of Women at High Risk of Breast Cancer Using OncoVue®
    Jupe, E. R.
    Pugh, T. W.
    Knowlton, N. S.
    DeFreese, D. C.
    CANCER RESEARCH, 2010, 70
  • [43] Using Breast Cancer Risk Associated Polymorphisms to Identify Women for Breast Cancer Chemoprevention
    Ziv, Elad
    Tice, Jeffrey A.
    Sprague, Brian
    Vachon, Celine M.
    Cummings, Steven R.
    Kerlikowske, Karla
    PLOS ONE, 2017, 12 (01):
  • [44] Colorectal cancer risk is lower in women with previous breast cancer.
    Newschaffer, CJ
    Topham, A
    Herzberg, T
    Weiner, S
    Weinberg, DS
    GASTROENTEROLOGY, 2000, 118 (04) : A705 - A705
  • [45] A Genomic Biomarker for Breast Cancer Development in High-Risk Women
    Bild, A. H.
    Sun, Y.
    Soldi, R.
    Conner, T.
    Walker, D.
    Werner, T.
    Spira, A.
    Andrulis, I
    Buys, S. S.
    Johnson, E.
    CANCER RESEARCH, 2009, 69 (24) : 726S - 726S
  • [46] Using breast cancer risk factors of women to estimate incidence of breast cancer in their sisters
    Mao, X.
    He, W.
    Eriksson, M.
    Lindstrom, L.
    Holowko, N.
    Lagercrantz, S. B.
    Humphreys, K.
    Easton, D.
    Hall, P. F.
    Czene, K.
    ANNALS OF ONCOLOGY, 2022, 33 : S184 - S184
  • [47] Phase II dose escalation trial of Avastin™ (bevacizumab) in women with previously treated metastatic breast cancer.
    Cobleigh, MA
    Miller, KD
    Langmuir, VK
    Reimann, JD
    Vassel, AV
    Novotny, WF
    Sledge, GW
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 301 - 301
  • [48] IBISII: a breast cancer prevention trial in postmenopausal women using the aromatase inhibitor anastrozole
    Cuzick, Jack
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (09) : 1377 - 1385
  • [49] Alcohol intake and metabolism among women at high risk for breast cancer.
    Terry, MB
    Kranick, JA
    Senie, RT
    Wang, Q
    Santella, RM
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2002, 155 (11) : s14 - s14
  • [50] Hydrotherapy following breast cancer surgery Phase II trial on hydrotherapy in women following breast cancer surgery
    Alves Siqueira, Rosana Barbosa
    Freitas-Junior, Ruffo
    Lopes, Priscila Souza
    Lagares, Marimilia Silva
    Viana, Fabiana Pavan
    Jesus Castro Mesquita, Thamara Marcia
    Soares, Leonardo Ribeiro
    BREAST JOURNAL, 2020, 26 (05): : 1107 - 1110
12345